• 1. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

Comprehensive Overview of tert-butyl exo-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate (CAS No. 744183-20-8)

The compound tert-butyl exo-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate (CAS No. 744183-20-8) is a highly specialized bicyclic organic molecule that has garnered significant attention in pharmaceutical and synthetic chemistry research. Its unique structural features, including the 8-azabicyclo[3.2.1]octane scaffold and the tert-butyl carboxylate protecting group, make it a valuable intermediate in the synthesis of complex bioactive molecules. Researchers and industry professionals often search for this compound due to its potential applications in drug discovery, particularly in the development of central nervous system (CNS) therapeutics and enzyme inhibitors.

One of the key reasons for the growing interest in tert-butyl exo-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate is its role as a precursor in the synthesis of tropane alkaloid derivatives. These derivatives are widely studied for their pharmacological properties, including their ability to modulate neurotransmitter systems. The exo-3-amino configuration in this compound is particularly noteworthy, as it influences the stereochemistry and binding affinity of resulting molecules. This aspect is frequently explored in academic papers and patent literature, making it a hotspot for researchers investigating structure-activity relationships (SAR).

In the context of modern drug development, the demand for tert-butyl-protected intermediates like this compound has surged. The tert-butyl group serves as a robust protecting strategy for amines and carboxylates, enabling selective reactions in multi-step syntheses. This is especially relevant in peptide chemistry and the design of prodrugs, where controlled deprotection is critical. Recent trends in green chemistry have also spurred interest in optimizing the synthesis of such intermediates to reduce waste and improve atom economy.

Another area where CAS No. 744183-20-8 is frequently discussed is in the field of asymmetric catalysis. The bicyclic framework of this compound can act as a chiral auxiliary or ligand in catalytic reactions, enhancing enantioselectivity. This aligns with the broader industry shift toward stereocontrolled synthesis, driven by regulatory requirements for chiral drugs. Researchers often query the stereochemical purity and scalable synthesis of this compound, reflecting its practical importance in large-scale pharmaceutical manufacturing.

From a commercial perspective, suppliers and distributors of tert-butyl exo-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate emphasize its high purity and stability under standard storage conditions. Analytical data, such as HPLC and NMR spectra, are critical for quality assurance and are commonly requested by buyers. The compound’s compatibility with automated synthesis platforms is another selling point, as it integrates well with high-throughput screening workflows in drug discovery.

Looking ahead, the versatility of 744183-20-8 ensures its continued relevance in cutting-edge research. Whether in the design of novel CNS-targeting agents or as a building block for bioconjugates, this compound exemplifies the intersection of synthetic efficiency and biological applicability. As the pharmaceutical industry increasingly prioritizes fragment-based drug design, intermediates like this will remain indispensable tools for medicinal chemists.

• 827045-73-8(Carbamic acid, [3-(diethylamino)propyl]-4-piperidinyl-, 1,1-dimethylethyl ester (9CI))
• 1305022-73-4(Tert-butyl 3-(ethylamino)-8-azabicyclo[3.2.1]octane-8-carboxylate)
• 174486-93-2(tert-Butyl 3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate)
• 1305235-96-4(Tert-butyl 3-(cyclopropylamino)-8-azabicyclo[3.2.1]octane-8-carboxylate)
• 917610-20-9(tert-butyl N-methyl-N-[2-(piperidin-2-yl)ethyl]carbamate)
• 902837-26-7(tert-Butyl 4-pyrrolidin-1-ylpiperidine-1-carboxylate)
• 207405-68-3(tert-butyl endo-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate)
• 652144-71-3(1-Pyrrolidinecarboxylic acid, 2-[2-(1-piperidinyl)ethyl]-, 1,1-dimethylethyl ester, (2S)-)
• 1363380-67-9(Exo-3-amino-9-boc-9-azabicyclo[3.3.1]nonane)
• 1303968-23-1(3-Amino-8-aza-bicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester hydrochloride)